GERI GROSSI: Open Payments
NPI 1992125223 · PORT HURON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,612 in 82 payments from 11 companies in 2025. Trend: 2023 $954 · 2024 $1,660 · 2025 $1,612
Food & beverage: $1,528Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $640 |
| Janssen Biotech, Inc. | 9 | $263 |
| Ardelyx, Inc. | 12 | $213 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $155 |
| Gilead Sciences, Inc. | 9 | $145 |
| Lilly USA, LLC | 2 | $61 |
| Ipsen Biopharmaceuticals, Inc | 2 | $37 |
| Celltrion USA Inc. | 2 | $28 |
| GENZYME CORPORATION | 1 | $26 |
| Fresenius Kabi USA, LLC | 1 | $24 |
Products named: RINVOQ, TREMFYA, IBSRELA, ENTYVIO, MAVYRET, LINZESS, SKYRIZI, OMVOH.
Industry payments across MI — which companies pay providers there.
